Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades

Analysts at Macquarie upgraded Ball Corporation (NYSE: BLL) from Neutral to Outperform. Ball shares closed at $66.34 on Monday.

Keefe Bruyette & Woods upgraded Berkshire Hills Bancorp, Inc. (NYSE: BHLB) from Market Perform to Outperform. The price target for Berkshire Hills Bancorp has been raised from $30 to $33. Berkshire Hills Bancorp shares closed at $29.53 on Monday.

Analysts at JP Morgan upgraded TETRA Technologies, Inc. (NYSE: TTI) from Neutral to Overweight. Tetra Technologies shares closed at $7.84 on Monday.

Analysts at Goldman Sachs upgraded Marcus & Millichap Inc (NYSE: MMI) from Sell to Neutral. Marcus & Millichap shares closed at $31.22 on Monday.

Analysts at Barclays upgraded Rio Tinto plc (ADR) (NYSE: RIO) from Equal-weight to Overweight.. Rio Tinto shares closed at $34.76 on Monday.

Compass Point upgraded Credit Acceptance Corp. (NASDAQ: CACC) from Sell to Neutral. Credit Acceptance shares closed at $170.40 on Monday.

Raymond James upgraded NEWTEK Business Services Corp (NASDAQ: NEWT) from Sell to Hold. Newtek Business Services shares closed at $16.60 on Monday.

Analysts at Goldman Sachs upgraded Paramount Group Inc (NYSE: PGRE) from Hold to Buy. Paramount Group shares closed at $17.89 on Monday.

Macquarie upgraded Domtar Corp (USA) (NYSE: UFS) from Neutral to Outperform. Domtar shares closed at $41.24 on Monday.

Latest Ratings for BLL

DateFirmActionFromTo
Oct 2019MaintainsBuy
Aug 2019MaintainsOverweight
Aug 2019DowngradesOutperformMarket Perform

View More Analyst Ratings for BLL
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (BHLB + BLL)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
CAAPOppenheimerDowngrades
ROSTMKM PartnersMaintains121.0
STAYNomuraDowngrades15.0
ROKUMacquarieMaintains170.0
BJDeutsche BankMaintains27.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

'No Surprises' Expected On Salesforce Earnings Call: Here's Why

Boston Scientific To Acquire Interventional Radiology Business Of CeloNova Biosciences, Upfront Payment Of $70M Plus Additional Regulatory/Sales Milestone Payments